Skip to content

Erector Spinae Block vs Conventional Analgesia for Postoperative Analgesia in PCNL

Sonographic Guided Erector Spinae Plane Block Versus Conventional Analgesia After Percutaneous Nephrolithotomy a Comparative Randomized Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06935006
Enrollment
50
Registered
2025-04-18
Start date
2025-05-01
Completion date
2026-05-01
Last updated
2025-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Percutaneous Nephrolithotomy (PCNL)

Brief summary

50 adult patients scheduled for percutaneous nephrolithotomy in Sohag university hospitals will be devided in two groups one of them will receive Sonographic guided erector spinae plane block using 20 ml volume of bupivacaine 0.25 percent and the other will receive conventional analgesia of 0.1 mg/kg IV morphine

Interventions

PROCEDURESonographic guided Erector spinae plane block

Ultrasound guided plane block using 20 ml of 0.25% bupivacaine at the level of transverse process of T8

0.1 mg/kg morphine intravenous pre operative

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* ASA 1 to ASA 2 18 to 60 years

Exclusion criteria

* patient refusal Significant neurological , psychiatric or neuromascular disease Drug abuse Pregnant or lactating women Suspected coagulopathy Morbid obesity Known allergy to some medications Septicaemia and local infection at block site

Design outcomes

Primary

MeasureTime frameDescription
Reduction of postoperative pain1 yearVAS score for pain measurement

Contacts

Primary ContactAhmed Mahmoud Azmy, Assistant lecturer
ahmedazmy19692@yahoo.com01004793896
Backup ContactFawzy Abbas, Assistant professor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026